Amevive alefacept: University of Utah researchers reported that in a Phase II study of 174 psoriasis patients, of whom 88 received two courses of Amevive, about

Biogen Inc. (BGEN), Cambridge, Mass. Product: Amevive alefacept ( LFA-3/IgG) Business: Autoimmune/Inflammation, Dermatology Therapeutic category: Immune modulation Target: CD2 receptor on T cells De...